KYMR affiliates report Form 144 share sales
KYMR affiliates reported proposed sales of Common Stock on Form 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KYMR affiliates reported proposed sales of Common Stock on Form 144. The notice lists multiple dispositions by Atlas Venture entities and by Bruce Booth on 04/15/2026, 04/22/2026, and 06/18/2026
Examples include Atlas Venture Fund X, L.P. proposing a sale of 92,169 shares on 06/18/2026 for $8,330,667.41, and Bruce Booth reporting 11,741 shares on 06/18/2026 for $1,056,443.24. The transactions are reported as resale of previously acquired common stock from a private placement.
Insights
Form 144s show proposed affiliate resales; filings are regulatory notices, not executed trades.
These Form 144 entries list proposed dispositions by affiliated holders, including Atlas Venture entities and Bruce Booth, with specific share counts and gross proceeds recorded on 04/15/2026, 04/22/2026, and 06/18/2026. Form 144 is a required notice for certain affiliate sales under resale rules.
Whether shares actually trade depends on market execution and any applicable transfer restrictions; subsequent filings or broker reports will show completion.
Notable single-day filings show larger dispositions on 06/18/2026, which may temporarily increase sell-side activity.
The excerpt lists several larger sale notices on 06/18/2026, including Atlas Venture Fund X's 92,169 shares and Atlas Venture Opportunity Fund I's 12,902 shares. These are presented as resale amounts with associated gross proceeds.
Execution, timing, and market impact depend on whether the holders use brokered transactions and any resale limitations disclosed elsewhere; follow-up market data and subsequent Form 4/144 amendments will clarify outcomes.
Key Figures
Key Terms
Form 144 regulatory
Private Placement financial
Issuer regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does KYMR's Form 144 filing show?
Who are the primary sellers listed in the KYMR excerpt?
What were the largest single dispositions shown in the excerpt?
Where were proceeds and transaction dates reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.
Keep reading
More on KYMR
- Sep 2, 2026 Kymera Therapeutics to Participate in Upcoming September Investor Conferences
- Sep 1, 2026 Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses
- Aug 5, 2026 Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update